Leaflet VIBROCIL 2.5mg / 0.25mg / ml nasal spray, suspension


Indicated for: nasal congestion; rhinitis

Substance: phenylephrine + dimetindene (adrenergic decongestant + antihistamine)

ATC: R01AD08 (Respiratory system | Decongestants and other nasal preparations for topical use | Corticosteroids)

The combination of phenylephrine and dimetindene is used for the treatment of symptoms of allergic rhinitis and nasal congestion. Phenylephrine acts as a decongestant, while dimetindene is an antihistamine that reduces allergic reactions such as itching and sneezing.

The medication is available in the form of nasal sprays or solutions and should be used as directed by your doctor. It is important not to exceed the recommended dose and to avoid long-term use without medical supervision.

Side effects may include dryness of the nasal mucosa, dizziness, drowsiness, or, in rare cases, severe allergic reactions.

Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of this combination.

General data about VIBROCIL 2.5mg / 0.25mg / ml

  • Substance: phenylephrine + dimetindene
  • Date of last drug list: 01-04-2026
  • Commercial code: W71785001
  • Concentration: 2.5mg / 0.25mg / ml
  • Pharmaceutical form: nasal spray, suspension
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: GLAXO WELLCOME S.A. - SPANIA
  • Holder: HALEON ROMANIA S.R.L. - ROMANIA
  • Number: 15282/2024/01
  • Shelf life: 2 years

Pharmaceutical forms available for phenylephrine + dimetindene

Concentrations available for phenylephrine + dimetindene

  • 2.5mg/0.25mg/g
  • 2.5mg/0.25mg/ml